Imidazole → HCID 22995910, compound
Reaction equation
[F:1][C:2]([F:22])([F:21])[S:3]([O:6][C:7]1[CH:16]=[CH:15][C:14]2[C:9](=[C:10]([CH:17]([OH:20])[CH2:18][OH:19])[CH:11]=[CH:12][CH:13]=2)[N:8]=1)(=[O:5])=[O:4].N1C=CN=C1.[Si:28](Cl)([C:31]([CH3:34])([CH3:33])[CH3:32])([CH3:30])[CH3:29].O>CN(C=O)C>[F:22][C:2]([F:1])([F:21])[S:3]([O:6][C:7]1[CH:16]=[CH:15][C:14]2[C:9](=[C:10]([CH:17]([OH:20])[CH2:18][O:19][Si:28]([C:31]([CH3:34])([CH3:33])[CH3:32])([CH3:30])[CH3:29])[CH:11]=[CH:12][CH:13]=2)[N:8]=1)(=[O:5])=[O:4]Participants
6
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
A solution of 12 g (35 mmol) of 2-trifluoromethanesulfonyloxy-8-(1,2-dihydroxyethyl)quinoline, of 5.33 g (78.3 mmol) of imidazole and of 5.63 g of tert-butyldimethylsilyl chloride in 280 ml of DMF is stirred at ambient temperature for 16 h. 800 ml of water are added and extraction is carried out with ethyl acetate (3×250 ml). The organic phases are combined, dried over magnesium sulfate, filtered and concentrated under vacuum. The residue is purified by silica chromatographic column (eluent: cyclohexane/ethyl acetate 8/2) to provide 13.8 g of 2-trifluoromethanesulfonyloxy-8-(1-hydroxy-2-tert-butyldimethylsilyloxyethyl)quinoline in the form of a yellow oil. (Yield: 91%)
Workup
- extractionextraction
- dry with materialdried over magnesium sulfate
- filtrationfiltered
- concentrationconcentrated under vacuum
- customThe residue is purified by silica chromatographic column (eluent: cyclohexane/ethyl acetate 8/2)
Sources & evidence
- ORD record
- ord-1656a92870ed44ceafb2eab874a363f9
- Source dataset
- uspto-grants-2003_09
- Patent number
- US06617336B1
Reaction notes
Loading…